Genlight MedTech was founded in 2020 in Hangzhou, is a sci-tech platform enterprise focused on industrializing cutting-edge technologies in the fields of neuroscience and neurosurgery. The company has established advanced technology platforms in brain-computer interface, medical lasers, and brain-computer chip, providing innovative instrumental solutions for neurological disorders. Developed products include a magnetic resonance-guided laser ablation system, an implantable closed-loop responsive neurostimulation system for epilepsy and Parkinson's disease, as well as an SEEG electrode, 2 of these products have received breakthrough designation from NMPA. Genlight MedTech believes in innovation and cares for the welfare of patients. With a global scope and integration between industry and research, we always strive to be a reliable leader in providing solutions in the neuromedical domain.
• Epilcure™ has been selected into the "Top Ten Innovative Cases of the Brain-Computer Interface Industry in 2024".
• Research and Development Center of High-tech Enterprises in Zhejiang Province
• SMEs in Zhejiang Province featuring specialization, refinement, distinctiveness and innovation
• The Most Investable Enterprise in Zhejiang Province
• Council Member Unit of the National Biomedical Enterprise Platform
• Hangzhou Future Unicorn
• China Future Unicorn
• Hangzhou Enterprise High-tech R&D Center
• MTl Asia Pacific 2023 Accelerator Program
• Series B+ funding(Tens of millions of RMB)
• Top 100 Emerging Chinese Medical device Enterprises
• LaserROTM received breakthrough device designation from NMPA
• Established a Graduate Joint Training Center with Zhejiang University of Technology
• Become a board member of Yuhang District Biomedical Industry Association
• Top 100 Innovative Medical Device Companies in China
• First Enrollment of Clinical Trial ofLaserROTM in China
• LaserRO™ won first prize in the 5th China Medical Device Innovation and Entrepreneurship Competition
• Epilcure™ received breakthrough device designation from NMPA
• Most Investment-Worthy Innovative Enterprise in Zhejiang
• Pre-Series A funding(Tens of millions of RMB)
• Acquisition of Hangzhou Nuowei Medical
• Series A funding(Tens of millions of RMB)
• The first implantation of Epilcure™
• Launch of Epilcure™ Multi-Center RCT
• Epilcure™ won first prize in the 4th China Medical Device Innovation and Entrepreneurship Competition
• Series B funding(Hundreds of millions of RMB)
• Venture 50 winner
• Genlight MedTech was established in Zhejiang Overseas High-Level Talents Innovation Park
• Reviewed by Hangzhou Future Sci-Tech City Management Committee as Priority Recommended Overseas High-Level Talent Project
• Angel funding(3.5 million RMB)
• Second Prize in the Hangzhou Overseas High-Level Talent Innovation and Entrepreneurship Competition
• The first-generation prototype of LaserRO™